Hamel Lawrence G

Chief Development Officer at TLPH

Sold, on record
$111k
Dollars the filings state
Form 4 sales
4
Latest Oct 15, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TLPHACELRX PHARMACEUTICALS INCChief Development Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale TLPHPlan not stated
    Sep 25 2017

    Sold 13,827 shares

    Hamel Lawrence G, Chief Development Officer

    Sold 16.8% of holdings68,504 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale TLPHPlan not stated
    Oct 2 +7 days

    Sold 10,161 shares at $5.29 ($54k)

    Hamel Lawrence G, Chief Development Officer

    Sold 19.5% of holdings ($276k position)41,964 shares leftFiling

  3. 3 Form 4 sale TLPHPlan not stated
    Sep 24 +357 days

    Sold 6,953 shares at $4.50 ($31k)

    Hamel Lawrence G, Chief Development Officer

    Sold 16.6% of holdings ($189k position)35,011 shares leftFiling

  4. 4 Form 4 sale TLPHPlan not stated
    Oct 15 +21 days

    Sold 5,216 shares at $5.00 ($26k)

    Hamel Lawrence G, Chief Development Officer

    Sold 14.9% of holdings ($175k position)29,795 shares left0.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Hamel Lawrence G
Source
Oct 15, 2018TLPHChief Development OfficerForm 4 sale5,216$26k14.9%Plan not statedSEC
Sep 24, 2018TLPHChief Development OfficerForm 4 sale6,953$31k16.6%Plan not statedSEC
Oct 2, 2017TLPHChief Development OfficerForm 4 sale10,161$54k19.5%Plan not statedSEC
Sep 25, 2017TLPHChief Development OfficerForm 4 sale13,82716.8%Plan not statedSEC